Literature DB >> 28190003

Telephone care co-ordination for tobacco cessation: randomised trials testing proactive versus reactive models.

Scott E Sherman1,2, Paul Krebs1,2, Laura S York3, Sharon E Cummins4, Ware Kuschner5,6, Sebnem Guvenc-Tuncturk7, Shu-Hong Zhu4.   

Abstract

OBJECTIVES: We conducted two parallel studies evaluating the effectiveness of proactive and reactive engagement approaches to telephone treatment for smoking cessation.
METHODS: Patients who smoked and were interested in quitting were referred to this study and were eligible if they were current smokers and had an address and a telephone number. The data were collected at 35 Department of Veterans Affairs (VA) sites, part of four VA medical centres in both California and Nevada. In study 1, participants received multisession counselling from the California Smokers' Helpline (quitline). In study 2, they received self-help materials only. Patients were randomly assigned by week to either proactive or reactive engagement, and primary care staff were blind to this assignment. Providers gave brief advice and referred them via the electronic health record to a tobacco co-ordinator. All patients were offered cessation medications. OUTCOME: Using complete case analysis, in study 1 (quitline), patients in the proactive condition were more likely than those in the reactive condition to report abstinence at 6 months (21.0% vs 16.4%, p=0.03). No difference was found between conditions in study 2 (self-help) (16.9% vs 16.5%, p=0.88). Proactive outreach resulted in increased use of cessation medications in both the quitline (70.1% vs 57.6%, p<0.0001) and the self-help studies (74.5% vs 48.2%, p<0.0001).
CONCLUSION: Proactive outreach with quitline intervention was associated with greater long-term abstinence. Both studies resulted in high rates of medication use. Sites should use a proactive outreach approach and provide counselling whenever possible. TRIAL REGISTRATION NUMBER: NCT00123682. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Tobacco cessation; proactive; quitline; veterans

Mesh:

Year:  2017        PMID: 28190003     DOI: 10.1136/tobaccocontrol-2016-053327

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  6 in total

1.  Proactive Population Health Strategy to Offer Tobacco Dependence Treatment to Smokers in a Primary Care Practice Network.

Authors:  Sara Kalkhoran; Elizabeth M Inman; Jennifer H K Kelley; Jeffrey M Ashburner; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2019-06-13       Impact factor: 5.128

2.  Health System Implementation of a Tobacco Quitline eReferral.

Authors:  Eve Angeline Hood-Medland; Susan L Stewart; Hien Nguyen; Mark Avdalovic; Scott MacDonald; Shu-Hong Zhu; Antonio Mayoral; Elisa K Tong
Journal:  Appl Clin Inform       Date:  2019-10-02       Impact factor: 2.342

3.  Pain and smoking study (PASS): A comparative effectiveness trial of smoking cessation counseling for veterans with chronic pain.

Authors:  Lori A Bastian; Mary Driscoll; Eric DeRycke; Sara Edmond; Kristin Mattocks; Joe Goulet; Robert D Kerns; Mark Lawless; Caroline Quon; Kim Selander; Jennifer Snow; Jose Casares; Megan Lee; Cynthia Brandt; Joseph Ditre; William Becker
Journal:  Contemp Clin Trials Commun       Date:  2021-08-20

4.  Telephone counselling for smoking cessation.

Authors:  William Matkin; José M Ordóñez-Mena; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-05-02

Review 5.  Strategies to improve smoking cessation rates in primary care.

Authors:  Nicola Lindson; Gillian Pritchard; Bosun Hong; Thomas R Fanshawe; Andrew Pipe; Sophia Papadakis
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

6.  Tobacco Cessation, Rural Residence, and Lung Cancer.

Authors:  Steven S Coughlin; Marlo Vernon; Ban Majeed; Catherine Clary; Justin Moore; K M Islam; Martha S Tingen
Journal:  J Environ Health Sci       Date:  2020-02-17       Impact factor: 3.433

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.